Crossmark

Safety profiles in the use of immune checkpoint inhibitors by patients with cancer and pre-existing autoimmune diseases

Crossref DOI link: https://doi.org/10.1016/j.medcli.2024.08.003

Published Print: 2025-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Santos Freitas, Júlia de Almeida

da Silva Neto, Marinho Marques

Freitas de Lima, Cleverton Kleiton

Amaral Boa Sorte, Ney Cristian

Bendicho, Maria Teresita

de Freitas Santos Júnior, Aníbal
Funding

Funding for this research was provided by:

Universidade do Estado da Bahia

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
License Information

Text and Data Mining valid from 2025-01-01

Text and Data Mining valid from 2025-01-01

stm-asf valid from 2025-01-01

stm-asf valid from 2025-01-01

stm-asf valid from 2025-01-01

stm-asf valid from 2025-01-01

stm-asf valid from 2025-01-01
More Information

This article is maintained by: Elsevier

Article Title: Safety profiles in the use of immune checkpoint inhibitors by patients with cancer and pre-existing autoimmune diseases

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2024.08.003

Content Type: article

Copyright: © 2024 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.